1/8 #TumorBoardTuesday
➡️This week's Thurs Case🎀 is here!

🔬We discussed locally advanced #PancreaticCancer--& sig of germline muts (ATM). @SirohiBhawna takes us on her pt’s treatment journey.

🗝️insights 🤔on locally advanced #PANCAN below!
#PancreaticCancerAwarenessMonth Image
1.5/8 #TumorBoardTuesday

👉👉 Don’t forget to pick up your 🆓 #CME credit by answering 2 quick❓
Here’s the post-test 🔗: bit.ly/3ws480C

ALL CME 🔗: integrityce.com/tbt Now...on to the case!
2/8 #TumorBoardTuesday
Thurs Case🎀
11/09/2021
Take🏠:

✅Upfront tx depends on pt- mFFX vs gem/nab-pac
✅Test all #PDAC for germline mut regardless of FH!‼️
✅Screen w annual MRI/EUS in gATM
✅Emerging 💊combos tx ATM-mut
#PANCAN req multi-D- role for palliative SBRT, ?IRE
2.5/8 #TumorBoardTuesday

📚We captured as much of @SirohiBhawna’s discussion, taking us through treatment of locally advanced #PDAC #LAPDAC as we could in this moment: twitter.com/i/events/14585…
3/8 #TumorBoardTuesday
Thursday Case🎀
11/09/2021

@SirohiBhawna presented a case of a 64 yo w locally advanced #PancreaticCancer (LAPAC) with PMH ovarian ca.

➡️There was a debate between mFFX vs gem/nab-pac
✅But, surprisingly 87% voted for mFFX! Image
4/8 #TumorBoardTuesday
Thursday Case🎀
11/09/21

LAPACT trial✅gem/nab-pac IS option
Retro👀 at gem/nab-pac vs mFFX➡️mFFX assoc w⬆️ORR, but=OS
@FogacciJoao presented another📄:gem/nab-pac better OS @ 1y, mFFX better @ 2y

pubmed.ncbi.nlm.nih.gov/31953079/
jamanetwork.com/journals/jamas…
5/8 #TumorBoardTuesday
Thurs Case🎀
11/09/2021

Pt starts mFFX➡️sxs👍, CA 19-9⬇️ ,
But😱peripheral neuropathy!

🤔What now❓
Tx break vs FOLFIRI vs 5FU/Cape❓
💡PANOPTIMOX✅maintenance 5-FU..but in met dz

➡️tx break...but ca progresses locally
➡️Chemo vs local tx next❓
6/8 #TumorBoardTuesday
Thurs Case🎀
11/09/21

Role of local tx still under🕵️:
LAP-07- no OS benefit of XRT
SBRT palliative benefits❓
Irreversible electroporation (IRE) - highly controversial

Pt tx w XRT⚡️5 mo PFS! But Dz progresses--ctDNA shows ATM mut

pubmed.ncbi.nlm.nih.gov/27139057/
7/8 #TumorBoardTuesday
Thurs Case🎀
11/09/2021

Which ➡️@SirohiBhawna’s mini-🐦 about ATM & #PANCAN

✅Germline testing for all #PDAC!
✅Screen pts w germline ATM mut for #PDAC
-- Annual MRI vs EUS
✅Screen in pts with BRCA muts- pt centered decision
pubmed.ncbi.nlm.nih.gov/30689033/
8/8 #TumorBoardTuesday
Thursday Case🎀
11/09/2021

🙏 Need better 🧰 for ATM mut PDAC
➡️ Combo ATR + PARP 💊 ❓
🤔 All ATM (or dMMR, or MSI) are 🚫created=

🤩Stay tuned for an EXCITING announcement about the next #TumorBoardTuesday!!
You won’t want to miss what’s in store!
#PostTest Q1️⃣ #CME #TumorBoardTuesday

@SirohiBhawna presented a case of ATM mutated #PancreaticCancer

🤔Which germline testing 🧪is indicated in patients with pancreatic cancer❓

👉🏽posttest🔗 bit.ly/3ws480C

👉🏽ALL CME🔗 integrityce.com/tbt

@MPishvaian #OncTwitter
#PostTest Q2️⃣ #CME #TumorBoardTuesday

🤔What proportion of #PancreaticCancer patients harbor an actionable somatic or germline mutation❓

👉🏼post-test 🔗: bit.ly/3ws480C

👉🏼ALL CME 🔗: bit.ly/TBTxCME

#PanCan #PancreaticCancerAwarenessMonth @MPishvaian

• • •

Missing some Tweet in this thread? You can try to force a refresh
 

Keep Current with #TumorBoardTuesday

#TumorBoardTuesday Profile picture

Stay in touch and get notified when new unrolls are available from this author!

Read all threads

This Thread may be Removed Anytime!

PDF

Twitter may remove this content at anytime! Save it as PDF for later use!

Try unrolling a thread yourself!

how to unroll video
  1. Follow @ThreadReaderApp to mention us!

  2. From a Twitter thread mention us with a keyword "unroll"
@threadreaderapp unroll

Practice here first or read more on our help page!

More from @TumorBoardTues

29 Oct
1/10 #TumorBoardTuesday
Thursday Case🎀
This week’s case: pt w #GEA not responding to FLOT w dMMR/MSI. Receives 3 doses of pembrolizumab->pCR!

💡Biomarker-based IO can be v successful, but better biomarkers needed‼️
➡️Explore wrap up below re: deploying IO in #UGI Image
2/10 #TumorBoardTuesday

👉👉 Don’t forget to pick up your 🆓 #CME credit by answering 2 quick ❓
Here is the post-test 🔗: bit.ly/3EgtZeE

ALL CME 🔗: integrityce.com/tbt Image
3/10 #TumorBoardTuesday
Thursday Case🎀

Take🏠messages:
We discussed #GastricCancer & immunotherapy (IO)
✅dMMR/MSI quite common- 8-22% of non-metastatic cases
✅Chemo less effective in dMMR disease, particularly 5-FU
✅High pCR with upfront IO
✅ctDNA may be a key biomarker
Read 13 tweets
15 Oct
1/12 #TumorBoardTuesday
Thurs 10/12/21 Case🎀
@ShaalanBeg @CancerCommons present a case of #PancreaticCancer that challenges us to🤔about cell signaling & mol bio➡️better outcomes.

📚We captured as much of the chat as we could:
twitter.com/i/events/14479…
#PanCan #KRAS #OncTwitter
2/12 #TumorBoardTuesday
Thurs Case🎀

Take🏠messages:
We discussed #PancreaticCancer & specific #KRAS mut
✅All KRAS muts aren’t ≠
✅KRAS G12R➡️⬆️autophagy
✅Autophagy= tumor can♻️cell components ➡️resistance
✅MEKi + autophagy inhib= strat for G12R
✅Repeat NGS on prog is🗝️!
3/12
#TumorBoardTuesday
Thursday Case🎀

👉👉 Don’t forget to pick up 🆓 #CME credit by answering 3 quick ❓
Here is the post-test 🔗: bit.ly/3Bzgply

ALL CME 🔗: integrityce.com/tbt
Read 15 tweets
7 Oct
1/10 #TumorBoardTuesday

🔬A discussion focused on precision med in cervical cancer led by @GauravGangwan15
➡️Here's the Thursday Case🎀

👉 Don’t forget to pick up your 🆓 #CME credit- answer 2 quick❓here: bit.ly/3A6ipjH

ALL CME 🔗: integrityce.com/tbt
2/10 #TumorBoardTuesday
Case🎀
Take🏠msgs re: stage IV #CervicalCancer & 🎯med.
✅Cervical ca =4th leading cause of ca☠️ in♀️around the🌍
✅Screen &💉key; some spirited debate re: 💉roll out
✅AJCC revised- consider HPV, incorp addtl imaging in staging

3/10 #TumorBoardTuesday
Case🎀
Take🏠messages cont’d:
✅NGS can yield 🗝️tx, even when🎯🧬are rare in a dz
✅CRAF🎯 💊 paired with MEK 💊. Why?
✅RAF inhib➡️ ⬆️MEK activation

📚We captured as much of @GauravGangwan15’s discussion as we could: twitter.com/i/events/14455…
Read 12 tweets
1 Oct
1/10 #TumorBoardTuesday

🔬We reviewed RET mutations as an actionable🎯 in practice!
➡️Here’s this week's Thursday Case🎀

👉👉 Don’t forget to pick up your 🆓 #CME credit by answering 2 quick❓
Here’s the post-test🔗: bit.ly/2W7Acck
ALL CME 🔗: integrityce.com/tbt
2/10 #TumorBoardTuesday
Take🏠messages:
RET muts are ⬆️in medullary thyroid cancer
✅Sensitive to multikinase 💊
✅Gatekeeper resistance muts overcome by specific💊
✅RET is also seen in other cancers, including 🫁
2.5/10 #TumorBoardTuesday
9/28/2021 Case 🎀

✅Repeat NGS w progression is🗝️strategy to tx resistance

@VivekSubbiah is truly the “RET Master”!
Read 14 tweets
27 Aug
Pls join us in welcoming @JohnEbbenMDPhD to #TumorBoardTuesday!! 🎊

Dr Ebben is an onc fellow from WI, interested in🧬med & immunotherapy. He’ll also debate🧀curds & the best🍦custard in WI! He’ll be assisting with case wrap up🎀

We’re excited to have him!! #TBTFellow 1/17 White male with short brown...
2/17 #TumorBoardTuesday Thursday Case🎀(08/24/21)

Bringing #ctDNA to bear to improve pts🙌🏽 @pashtoonkasi shows us how we can♻️ 🎯therapies to extend survival.

We go deep -🔬molecular biology➡️clinical trials➡️pt case.

👉🏽Don’t forget🆓#CME credit: bit.ly/3B9i6Wd
3/17 #TumorBoardTuesday Thursday Case🎀(08/24/21)

📚We captured as much of @pashtoonkasi's discussion as we could in this moment:
#ColorectalCancer #CRC #OncTwitter

twitter.com/i/events/14288…
Read 19 tweets
9 Jul
#TumorBoardTuesday

THANK YOU to @KristenCiombor for leading us through a🗣️on pMMR CRC w/ dMMR liver mets

AND thank you for @fireflyann for leading our #PatientExperience 🗣️as well

👉Don’t forget your🆓#CME credit-answer 3 quick❓
Here's the postest🔗
surveymonkey.com/r/DMN786G
#TumorBoardTuesday
Thursday Case🎀(Reverse jet-lag edition✈️)
(07/06 and 07/07/21)

We🗣️ #ColorectalCancer and:
✅1st line Tx for dMMR met CRC
✅✔️ing MMR status EVEN in patients with Lynch Syndrome
✅Tumor heterogeneity

We captured the🗣️in this moment:
twitter.com/i/events/14131…
#TumorBoardTuesday
Thursday Case🎀
(From 07/06 and 07/07/21)

In the #PatientExperience 🗣️we added:
✅Defining the "lingo", e.g.
👉dMMR = MSI-high
👉pMMR = MS-stable
✅Ensuring tumor testing - and🗣️results w/ docs
✅Scanxiety

Also captured in this moment:
twitter.com/i/events/14132…
Read 18 tweets

Did Thread Reader help you today?

Support us! We are indie developers!


This site is made by just two indie developers on a laptop doing marketing, support and development! Read more about the story.

Become a Premium Member ($3/month or $30/year) and get exclusive features!

Become Premium

Too expensive? Make a small donation by buying us coffee ($5) or help with server cost ($10)

Donate via Paypal

Thank you for your support!

Follow Us on Twitter!

:(